Yahoo
HKSE - Delayed Quote HKD

Shanghai Bio-heart Biological Technology Co., Ltd. (2185.HK)

0.965 -0.005 (-0.52%)
At close: 3:53:48 PM GMT+8
View in AlphaSpace Currency in CNY All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Cash Flow from Operating Activities, Indirect
-71,584 -67,665 -118,444 -49,028 -140,616
Cash Flow from Investing Activities
-23,612 -195,987 -47,140 -28,856 -100,686
Cash Flow from Financing Activities
336 153,812 -2,442 -5,819 -35,178
Cash and Cash Equivalents, End of Period
92,172 92,283 202,386 369,438 451,318
Cash Flow, Supplemental
Free Cash Flow to Firm
-57,849.736 -52,619.423 -98,513 -112,128 -121,171
Capital Expenditure, Calculated
9,767 7,637 47,140 17,970 30,038
Issuance of Capital Stock
0 0 0 0 0
Repurchase of Capital Stock
0 0 -322 -561 -2,146
12/31/2022 - 12/23/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: